BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23569010)

  • 1. The value of preoperative PET-CT in papillary thyroid cancer.
    Kim BS; Ryu HS; Kang KH
    J Int Med Res; 2013 Apr; 41(2):445-56. PubMed ID: 23569010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of central lymph node metastasis from papillary thyroid microcarcinoma by 18F-fluorodeoxyglucose PET/CT and ultrasonography.
    Byun BH; Jeong UG; Hong SP; Min JJ; Chong A; Song HC; Bom HS
    Ann Nucl Med; 2012 Jul; 26(6):471-7. PubMed ID: 22467230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
    Kim MH; Ko SH; Bae JS; Lee SH; Jung CK; Lim DJ; Baek KH; Kim SH; Lee JM; Kang MI; Cha BY
    Thyroid; 2013 Nov; 23(11):1452-60. PubMed ID: 23688271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.
    Choi EK; Chong A; Ha JM; Jung CK; O JH; Kim SH
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):73-79. PubMed ID: 28329426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma.
    Kim BS; Kim SJ; Kim IJ; Pak K; Kim K
    Thyroid; 2012 Jul; 22(7):725-9. PubMed ID: 22524470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of predictability of F-18 fluorodeoxyglucose-PET/CT in the recurrence of papillary thyroid carcinoma.
    Kim SK; So Y; Chung HW; Yoo YB; Park KS; Hwang TS; Kim B; Lee WW
    Cancer Med; 2016 Oct; 5(10):2756-2762. PubMed ID: 27539659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
    Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M
    Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma.
    Jung JH; Kim CY; Son SH; Kim DH; Jeong SY; Lee SW; Lee J; Ahn BC
    PLoS One; 2015; 10(12):e0144152. PubMed ID: 26636824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
    Choi JW; Yoon YH; Yoon YH; Kim SM; Koo BS
    Ann Surg Oncol; 2011 May; 18(5):1306-11. PubMed ID: 21140231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
    Nascimento C; Borget I; Al Ghuzlan A; Deandreis D; Hartl D; Lumbroso J; Berdelou A; Lepoutre-Lussey C; Mirghani H; Baudin E; Schlumberger M; Leboulleux S
    Thyroid; 2015 Apr; 25(4):437-44. PubMed ID: 25633259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management.
    Schreinemakers JM; Vriens MR; Munoz-Perez N; Guerrero MA; Suh I; Rinkes IH; Gosnell J; Shen WT; Clark OH; Duh QY
    World J Surg Oncol; 2012 Sep; 10():192. PubMed ID: 22985118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
    Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.
    Kim H; Na KJ; Choi JH; Ahn BC; Ahn D; Sohn JH
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1569-76. PubMed ID: 25971994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?
    Muñoz Pérez N; Villar del Moral JM; Muros Fuentes MA; López de la Torre M; Arcelus Martínez JI; Becerra Massare P; Esteva Martínez D; Cañadas Garre M; Coll Del Rey E; Bueno Laraño P; Ferrón Orihuela JA
    Langenbecks Arch Surg; 2013 Jun; 398(5):709-16. PubMed ID: 23624819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer.
    Yoon S; An YS; Lee SJ; So EY; Kim JH; Chung YS; Yoon JK
    Medicine (Baltimore); 2015 Dec; 94(48):e2063. PubMed ID: 26632889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic characteristics of synchronous primary thyroid cancer detected by initial staging 18F-FDG PET-CT examination in patients with underlying malignancy.
    Kim BH; Lee CH; Kim SJ; Jeon YK; Kim SS; Kim YK; Kim IJ
    Thyroid; 2013 Nov; 23(11):1431-6. PubMed ID: 23510334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative shear wave elastography as a prognostic implication of papillary thyroid carcinoma (PTC): elasticity index can predict extrathyroidal extension (ETE).
    Park YJ; Kim JA; Son EJ; Youk JH; Park CS
    Ann Surg Oncol; 2013 Aug; 20(8):2765-71. PubMed ID: 23463092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming the limitations of fine needle aspiration biopsy: detection of lateral neck node metastasis in papillary thyroid carcinoma.
    Jun HH; Kim SM; Kim BW; Lee YS; Chang HS; Park CS
    Yonsei Med J; 2015 Jan; 56(1):182-8. PubMed ID: 25510763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
    Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
    Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.